"In AstraZeneca's workplace, all employees were equal, but some were more equal than others," the complaint alleged. AstraZeneca engaged in purposeful age discrimination when it terminated several ...
Despite China’s investigations into insurance fraud, allegedly illegal importation of unapproved drugs and improper collection of patient data that have implicated senior executives, AstraZeneca CEO ...
While AstraZeneca’s previous efforts to showcase the power of science have taken a broader approach, highlighting clinical discoveries, new technologies and sustainability work, the drugmaker’s newest ...
AstraZeneca on Tuesday employed for the first time diversity and inclusion broker-dealers as part of its bond syndicate underwriting a US$2.25bn debt offering, according to bankers and Refinitiv data.
AstraZeneca is expanding its prospects in cardiometabolic disease, paying $1.2 billion to begin a partnership on eight programs that include obesity drug candidates with potential advantages over ...
IN A COUNTRY struggling to find reasons for cheer, British life sciences offer a ray of hope. The £108bn ($145bn) industry employs more than 300,000 people, many in high-value jobs, and Britain is a ...
AstraZeneca Plc said it’s pausing a planned £200 million ($235 million) expansion of its headquarters in the UK, a further blow to the nation’s life sciences ambitions after Merck & Co. scrapped a ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceutical ...
What's Astrazeneca Pharma India Ltd share price today. Get Astrazeneca Pharma India Ltd latest news on BSE/NSE stock price live updates, Astrazeneca Pharma India Ltd financial results and overview, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results